» Articles » PMID: 38138118

Mathematical Modeling of the Lethal Synergism of Coinfecting Pathogens in Respiratory Viral Infections: A Review

Overview
Journal Microorganisms
Specialty Microbiology
Date 2023 Dec 23
PMID 38138118
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A virus (IAV) infections represent a substantial global health challenge and are often accompanied by coinfections involving secondary viruses or bacteria, resulting in increased morbidity and mortality. The clinical impact of coinfections remains poorly understood, with conflicting findings regarding fatality. Isolating the impact of each pathogen and mechanisms of pathogen synergy during coinfections is challenging and further complicated by host and pathogen variability and experimental conditions. Factors such as cytokine dysregulation, immune cell function alterations, mucociliary dysfunction, and changes to the respiratory tract epithelium have been identified as contributors to increased lethality. The relative significance of these factors depends on variables such as pathogen types, infection timing, sequence, and inoculum size. Mathematical biological modeling can play a pivotal role in shedding light on the mechanisms of coinfections. Mathematical modeling enables the quantification of aspects of the intra-host immune response that are difficult to assess experimentally. In this narrative review, we highlight important mechanisms of IAV coinfection with bacterial and viral pathogens and survey mathematical models of coinfection and the insights gained from them. We discuss current challenges and limitations facing coinfection modeling, as well as current trends and future directions toward a complete understanding of coinfection using mathematical modeling and computer simulation.

References
1.
Greer R, McErlean P, Arden K, Faux C, Nitsche A, Lambert S . Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections?. J Clin Virol. 2009; 45(1):10-5. PMC: 7185458. DOI: 10.1016/j.jcv.2009.03.008. View

2.
Handel A, Longini Jr I, Antia R . Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics. 2010; 1(3):185-95. PMC: 2796779. DOI: 10.1016/j.epidem.2009.09.001. View

3.
Gill J, Sheng Z, Ely S, Guinee D, Beasley M, Suh J . Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010; 134(2):235-43. PMC: 2819217. DOI: 10.5858/134.2.235. View

4.
Rich H, McCourt C, Zheng W, McHugh K, Robinson K, Wang J . Interferon Lambda Inhibits Bacterial Uptake during Influenza Superinfection. Infect Immun. 2019; 87(5). PMC: 6479047. DOI: 10.1128/IAI.00114-19. View

5.
van der Sluijs K, van Elden L, Nijhuis M, Schuurman R, Pater J, Florquin S . IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004; 172(12):7603-9. DOI: 10.4049/jimmunol.172.12.7603. View